On-treatment modified Glasgow Prognostic Score (mGPS) in hepatocellular carcinoma treated with atezolizumab and bevacizumab provides prognostic information.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationWorld journal of urology
View this publicationJCI insight
View this publicationNature communications
View this publicationJAMA oncology
View this publicationCancer research
View this publicationEuropean journal of cancer (Oxford, England : 1990)
View this publicationInsights into imaging
View this publicationAktuelle Urologie
View this publicationUrologie (Heidelberg, Germany)
View this publication